Turtlemint Fintech's Rs 883 crore IPO opens for subscription. Check brokerage review, GMP and other details
The IPO of insurance distribution platform Turtlemint Fintech Solutions opened for subscription today and will close on June 23. The company's shares were commanding a
The IPO of insurance distribution platform Turtlemint Fintech Solutions opened for subscription today and will close on June 23. The company's shares were commanding a grey market premium (GMP) of around 2%, indicating a muted listing expectation.The IPO comprises a fresh issue worth Rs 660.7 crore and an offer for sale (OFS) of Rs 221.9 crore, taking the total issue size to about Rs 883 crore. The price band has been fixed at Rs 144-152 per share.About the companyTurtlemint is a technology-enabled insurance distribution platform that connects customers, insurance advisors and insurers through a digital ecosystem.
The company operates one of India's largest Point of Sales Person (PoSP) networks with over 5.07 lakh certified PoSPs and 6.32 lakh digital partners, offering life, health and motor insurance products. It has also expanded into mutual funds and loan distribution.The company plans to utilise the proceeds from the fresh issue for technology and product development, cloud infrastructure, marketing initiatives, lease payments, working capital requirements of its subsidiary and inorganic growth opportunities.Financially, the company reported revenue of Rs 662.7 crore in FY25, recovering sharply from the previous year.
However, it continues to remain loss-making, reporting a net loss of Rs 194 crore during the year.Brokerages remain mixedSMIFS has assigned a 'Subscribe' rating to the IPO, citing Turtlemint's leadership in the PoSP distribution business, nationwide reach, diversified insurer partnerships and long-term growth opportunities in India's underpenetrated insurance market.The brokerage said the company is well placed to benefit from rising insurance penetration, improving advisor productivity, AI-led automation, cross-selling opportunities and expansion into adjacent financial products.Swastika Investmart, meanwhile, gave an 'avoid' recommendation, saying the IPO is suited for long-term, high-risk investors betting on market leadership and not ideal for short-term/listing-gain seekers.With a modest GMP of around 2%, grey market signals suggest expectations of a limited listing premium, while the long-term investment case will largely depend on the company's ability to translate its scale into sustained profitability.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own.
These do not represent the views of Economic Times)